In this presentation, A/Prof Bateson will review the role and rationale for performing a co-test within the National Cervical Screening Program and revisit eligibility for a self-collected vaginal HPV sample. The co-test  is used for patients at higher risk of cervical screening including those with symptoms suggestive of cervical cancer and as part of Test of Cure following treatment of histology-proven high grade lesions.